CN Patent

CN103751763A — 用于预防或治疗血管阻塞损伤的方法

Assigned to Stealth Peptides International Inc · Expires 2014-04-30 · 12y expired

What this patent protects

本发明提供了预防或治疗哺乳动物对象中的心脏缺血-再灌注损伤的方法。所述方法包括将有效量的芳香族阳离子肽给药至需要该芳香族阳离子肽的所述对象，其中所述肽为D-Arg-26-Dmt-Lys-Phe-NH 2 （SS-31）。

USPTO Abstract

本发明提供了预防或治疗哺乳动物对象中的心脏缺血-再灌注损伤的方法。所述方法包括将有效量的芳香族阳离子肽给药至需要该芳香族阳离子肽的所述对象，其中所述肽为D-Arg-26-Dmt-Lys-Phe-NH 2 （SS-31）。

Drugs covered by this patent

elamipretide-hydrochloride (ELAMIPRETIDE HYDROCHLORIDE)

Patent Metadata

Patent number: CN103751763A
Jurisdiction: CN
Classification: —
Expires: 2014-04-30
Drug substance claim: No
Drug product claim: No
Assignee: Stealth Peptides International Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.